Insempra signs exclusive global distribution deal with Brenntag
Brenntag will sell Insempra's Omega-7 biolipid, CosVivet ActiLipid O7, to beauty and personal care markets worldwide under a broader strategic collaboration.
See the latest news and media coverage for Insempra. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing sustainable bio-based ingredients
insempra.bioLast updated
In short: Insempra signed a global Omega-7 distribution deal and completed a $20 million Series A.
Brenntag will sell Insempra's Omega-7 biolipid, CosVivet ActiLipid O7, to beauty and personal care markets worldwide under a broader strategic collaboration.
Salerno, who joined the management team on 1 August 2025, will strengthen the commercial team and support product launches as the company brings more bio-based ingredients to market.
Produced via precision fermentation, it is 100% natural, vegan and drop-in compatible, and was introduced at in-cosmetics Global in Amsterdam.
Solena raises $6.7 million from Sir David Harding, SynBioVen and Insempra to scale production and prepare a launch within three years.
The new product will be offered exclusively by Brenntag Beauty & Personal Care worldwide and will be introduced this month at the in ...
Lipids are fatty, waxy or oily compounds that typically come in the form of fats and oils. As a result, they are heavily used in...
EQT Ventures leads the $20 million Series A financing round, after Insempra (formerly Origin.Bio) has already ...
German biotech Insempra has successfully completed a $20 million Series A financing round. Insempra enables businesses to transform their ingredient lists away from harmful chemicals...
Track Insempra and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Insempra and other trending companies.